!!Projects per year
Fingerprint
- 6 Ähnliche Profile
Kooperationen und Spitzenforschungsbereiche der letzten fünf Jahre
-
P-PEAKS UTI: Personalized-Phage Against E. Coli with IV Antibiotic to Knockout Stable Biofilms in Urinary Tract Infections
Pirnay, J.-P. (Leitende(r) Forscher/-in)
1/06/26 → 31/05/30
Projekt: Forschung › HORIZON
-
PHAGES-AntiPERS: Phage Therapy Antipersister strategy
Pirnay, J.-P. (Leitende(r) Forscher/-in)
1/04/25 → 31/03/28
Projekt: Forschung › Walloon Region
-
RESILIENCE-R: First research action for Medical counter measures performed in the frame of the RESILIENCE FPA consortium
Pirnay, J.-P. (Leitende(r) Forscher/-in) & Martin, A. (Forschende)
1/11/24 → 31/10/27
Projekt: Forschung › EDF
-
Research in support of personalized bacteriophage therapy of difficult-to-treat infections
Merabishvili, M. (Forschende), Pirnay, J.-P. (Forschende), Steurs, G. (Forschende) & Cochez, C. (Forschende)
1/01/24 → 31/12/27
Projekt: Forschung › DFR
-
SynPhage : Synthetic Phage
Pirnay, J.-P. (Leitende(r) Forscher/-in), Glonti, T. (Forschende) & Goossens, M. (Forschende)
1/11/21 → 2/11/25
Projekt: Forschung › Research
-
Pyrogenicity of phage active pharmaceutical ingredients used for personalized therapy in Belgium
Willocx, M., Pirnay, J. P., Merabishvili, M., Laurent, F., Clouet, S., Lavigne, R., Ceyssens, P. J. & Vanhee, C., Juni 2026, in: European Journal of Pharmaceutics and Biopharmaceutics. 223, 115068.Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
Open Access -
Rethinking informed consent in phage therapy: why location and approach matter
Nir-Paz, R., Pirnay, J. P., Ferry, T., Drulis-Kawa, Z., Classen, A. Y., Scobie, A. I., Lester, R., Katvan, E., Hafkemeyer, S., McCallin, S. & Suh, G. A., Aug. 2026, in: Clinical Microbiology and Infection. 32, 8, S. 1211-1215 5 S.Publikation: Beitrag in Fachzeitschrift › Kommentar/Debatte
-
Single Treatment of Mature 3D Single-, Dual- and Poly-Species Biofilms Using a Combination Therapy of Phage or Phage-Hetero-Cocktails and Ciprofloxacin
Glonti, T., Aktan, M. K., Cochez, C., Zayed, N., Braem, A., Teughels, W. & Pirnay, J. P., Juni 2026, in: Antibiotics. 15, 6, 537.Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
Open Access -
Towards a reference methodology for bacteriophage susceptibility testing – position paper of the EUCAST Phage Susceptibility Testing Subcommittee
G.VukoticGoranEUCAST Phage Susceptibility Testing Subcommittee, 2026, (Angenommen/Im Druck) in: Clinical Microbiology and Infection.Publikation: Beitrag in Fachzeitschrift › Kommentar/Debatte
-
Bacteriophage-based veterinary products: aligning regulatory framework and development challenges for market integration
Antoine, C., Mackay, D., Midtlyng, P., Kleppen, H. P., Palić, D., Pirnay, J. P., Thiry, D. & Thiry, E., Aug. 2025, in: Biologicals. 91, 101847.Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
Open Access
-
Designing potent therapeutic cocktails using the naturally occurring bacteriophage grouping model
Glonti, T. (Co-author) & Pirnay, J.-P. (Co-author)
6 Sept. 2024Aktivität: Gespräch oder Vortrag › Vortrag
-
Burn or trauma scoring: experience of the burn unit of the Queen Astrid Military Hospital during the terror attacks on 22nd March 2016.
Bruyninckx, L. (Co-author), Jennes, S. (Co-author), Pirnay, J.-P. (Co-author) & de Schoutheete, J.-C. (Co-author)
28 Apr. 2024Aktivität: Gespräch oder Vortrag › Scientific poster presentation
-
Design of phage cocktails as a harness against antimicrobial resistance in Pseudomonas aeruginosa and Klebsiella pneumoniae
Glonti, T. (Co-author) & Pirnay, J.-P. (Co-author)
14 Sept. 2024Aktivität: Gespräch oder Vortrag › Vortrag
-
ADDRESSING RISK FACTORS MAY LEAD TO BROADER USE OF PHAGE THERAPEUTICS
Glonti, T. (Co-author) & Pirnay, J.-P. (Co-author)
15 Okt. 2024Aktivität: Gespräch oder Vortrag › Vortrag
Auszeichnungen
-
Martin Ramelot research prize
Pirnay, J.-P. (Empfänger/-in) & Merabishvili, M. (Empfänger/-in), 11 Okt. 2009
Auszeichnung